COCP Cocrystal Pharma Inc.

3.12
-0.31  -9%
Previous Close 3.43
Open 3.27
Price To Book 0.84
Market Cap 93359997
Shares 29,923,076
Volume 30,031
Short Ratio
Av. Daily Volume 44,638

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2a initial data due December 2018.
CC-31244
Hepatitis C
Phase 1 trial to be initiated 1H 2019.
CC-42344
Influenza

Latest News

  1. Cocrystal Pharma Announces Presentation at the RespiDART 2018: Frontiers in Drug Development Against Respiratory Viruses Conference
  2. WeissLaw LLP: Cocrystal Pharma, Inc. is the Subject of a Legal Investigation
  3. DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Cocrystal Pharma, Inc. (Formerly BioZone Pharmaceuticals, Inc.) and Encourages Investors with Losses of $100,000 to Contact the Firm
  4. FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Cocrystal Pharma, Inc. f/k/a/ BioZone Pharmaceuticals, Inc. (COCP) and Lead Plaintiff Deadline – November 19, 2018
  5. Detailed Research: Economic Perspectives on Cocrystal Pharma, Genius Brands International, Gemphire Therapeutics, Global Water Resources, Infrastructure and Energy Alternatives, and Condor Hospitality Trust — What Drives Growth in Today's Competitive Landscape
  6. DEADLINE MONDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Cocrystal Pharma, Inc. (Formerly BioZone Pharmaceuticals, Inc.) and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm
  7. The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of COCP, ABBV, CHGG, HON and DY
  8. COCP DEADLINE NOTICE ALERT: Rosen Law Firm Reminds Cocrystal Pharma, Inc. Investors of Important Nov. 19 Deadline in First Filed Case – COCP
  9. LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Cocrystal Pharma, Inc. To Contact The Firm
  10. DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Cocrystal Pharma, Inc. f/k/a/ BioZone Pharmaceuticals, Inc. (COCP) and Lead Plaintiff Deadline - November 19, 2018
  11. SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cocrystal Pharma, Inc. f/k/a BioZone - COCP
  12. FINAL DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Cocrystal Pharma, Inc. (Formerly BioZone Pharmaceuticals, Inc.) and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm
  13. SHAREHOLDER ALERT: APOG COCP COST TRVN HON DY ALGN AQUA SONS TSRO: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
  14. Pawar Law Group Announces a Securities Class Action Lawsuit Against Cocrystal Pharma, Inc. – COCP
  15. Biotech Stock Roundup: Gilead, Regeneron Present Data, Cocrystal Pharma Surges
  16. Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against Cocrystal Pharma, Inc. 
  17. CLASS ACTION UPDATE for MCHP, COCP and ALNY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
  18. 6-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Cocrystal Pharma, Inc. (Formerly BioZone Pharmaceuticals, Inc.) and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm